SAM
SOPH icon

Silvercrest Asset Management’s SOPHiA GENETICS SOPH Stock Holding History

Silvercrest Asset Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.24M Buy
+1,428,470
New +$7.25M 0.05% 387

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return

Silvercrest Asset Management's SOPH Position: Q2 2026 in Review

Silvercrest Asset Management opened a new position in SOPHiA GENETICS (SOPH) in Q2 2026: 1,428,470 shares worth $8.24M. The stake represents 0.05% of the portfolio and ranks #387 among its holdings.

68 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Silvercrest Asset Management held 1,428,470 shares of SOPHiA GENETICS worth $8.24M as of Q2 2026.
  • SOPHiA GENETICS was a new Silvercrest Asset Management position in Q2 2026.
  • SOPHiA GENETICS made up 0.05% of Silvercrest Asset Management's portfolio in Q2 2026, its #387 holding.
  • 68 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.